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Critically Appraised Paper
Summary of: Newall C, Stockley RA and Hill SL (2005): 
Exercise training and inspiratory muscle training in patients 
with bronchiectasis. Thorax 60: 943–948. [Prepared by 
Mark Elkins CAP Editor.]
Question: For patients with bronchiectasis, does pulmonary 
rehabilitation either with or without inspiratory muscle 
training (IMT) improve exercise tolerance? Design: 
Randomised controlled trial. Setting: Outpatient-based 
pulmonary rehabilitation program of a UK hospital. 
Patients: Patients with bronchiectasis confirmed by high-
resolution computer tomography. Exclusion criteria 
included concomitant emphysema, an acute exacerbation in 
the previous six weeks, long-term oral corticosteroid use, 
and significant co-morbidities. Thirty-two patients were 
randomised to pulmonary rehabilitation plus IMT (PR-
IMT) (n = 12), pulmonary rehabilitation plus sham IMT 
(PR-Sham) (n = 11), or a control group with no intervention 
(n = 9). Interventions: Pulmonary rehabilitation consisted 
of exercise training and multidisciplinary education 
sessions for eight weeks. Exercise consisted of three 45-
minute periods per week with a target exercise intensity of 
80% of the peak heart rate achieved on an initial maximal 
incremental exercise test. Two sessions per week were 
performed at the hospital and involved cycling, treadmill 
walking, and stair climbing. A third session of walking 
was performed at home, using the Borg dyspnoea scale to 
guide intensity. IMT was performed for 15 minutes twice 
daily over the eight-week period using a pressure threshold 
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device. Pressure was set at 30% of the patient’s maximal 
inspiratory pressure and increased by 5% each week to a 
maximum of 60%. Sham IMT followed the same regimen 
except that the pressure was always 7 cmH20. Outcomes: The 
incremental shuttle walk test, endurance exercise capacity, 
and respiratory muscle strength were assessed in all groups 
at baseline and at the end of the program. The endurance 
exercise test involved walking on a treadmill at 85% of peak 
oxygen uptake. Results: Over the eight weeks, improvement 
in the incremental shuttle walk test was significantly greater 
in the PR-IMT group (by 113 m, 95% CI 45 to 182) and PR-
Sham group (by 86 m, 95% CI 42 to 130) than the control 
group. Similarly, change in endurance exercise capacity was 
significantly better in the PR-IMT group (by 720 m, 95% CI 
342 to 1098) and PR-Sham group (by 505 m, 95% CI 128 to 
883) than the control group. Change in maximal inspiratory 
pressure was significantly better in the PR-IMT group (by 
23 cmH2O, 95% CI 10 to 36) and the PR-Sham group (by 
14 cmH2O, 95% CI 2 to 25) than that seen in the control 
group. The inclusion of IMT did not produce a statistically 
significant benefit over pulmonary rehabilitation alone for 
these outcomes during the training period. Conclusion: 
Pulmonary rehabilitation with or without IMT improves 
exercise tolerance and inspiratory muscle strength in 
subjects with bronchiectasis.
Effect sizes calculated by CAP editor based upon original 
data in paper.
Commentary
There are clear evidence-based guidelines regarding PR for 
chronic obstructive pulmonary disease (COPD). At present 
the recommendation to offer PR in other respiratory diseases 
is based on expert opinion rather than sound scientific 
evidence. This study makes an important contribution 
to the current PR literature as it provides evidence from 
a rigorously designed clinical trial in support of PR for 
bronchiectasis. The sample size in the study is small and 
therefore confirmation of study findings in further trials is 
essential. Despite this there are a number of key messages 
for clinicians involved in the delivery of PR.
Although the components of treatment were different in the 
two PR groups, both approaches improved exercise capacity 
during the training period. The incorporation of intensive 
IMT into PR did not significantly improve this immediate 
effect on exercise capacity. This suggests that the format 
and content of the PR program can be varied to meet the 
needs of the patient provided patients adhere to a minimum 
amount of exercise training. The two PR groups were also 
followed up three months after the training period. Exercise 
capacity had declined marginally in the PR-IMT group and 
significantly in the PR-Sham group. This suggests that there 
is a need for a maintenance process after PR in bronchiectasis 
and that intensive IMT may prolong the benefits of PR.
The change in health status according to the St George 
Respiratory Questionnaire was significantly better in the 
PR-IMT group than the control group. Interestingly, the 
authors do not compare the PR groups for this outcome. 
Calculating from data in the paper, the change in health 
status at the end of training is significantly better in the PR-
IMT group than the PR-Sham group (difference 10 units, 
95% CI 4.2 to 15.8). This exceeds the minimum clinically 
important difference for patients with COPD estimated 
by Jones (2005). A number of patients dropped out of this 
study due to exacerbations. PR programs need to develop 
strategies to enable patients to modify their exercise training 
during an exacerbation and build up exercise tolerance 
during recovery.
Evidence to support the benefit of PR in specific disease 
populations is essential especially since demand for PR is 
likely to exceed resources in many centres. Clinicians need 
information to direct selection of respiratory patients and 
the essential components of PR and to develop strategies 
to maintain long-term benefit. This study provides such 
evidence.
Judy Bradley
Health and Rehabilitation Sciences Research Institute, 
University of Ulster
Fidelma Moran
School of Health Sciences, University of Ulster
Reference
Jones P (2005): J Chronic Obstruct Pulmonary Dis 2: 75–79.
